Biotech deals surge to record as fear of missing out grips Big Pharma

Biotech deals have surged to a record high as Big Pharma experiences fear of missing out, driven by the impending expiration of patents on profitable drugs, prompting pharmaceutical companies to seek new blockbuster medicines.